中国 EN 400-660-9091

联系我们

电话:025-68037686

地址:江苏生命科技创新园F6幢1层

订购:nanjing03@biogot.com

服务:biorase01@biogot.com

合作:lvyun@biogot.com

支持:may@biogot.com

Bioworld引用文献(23852),当前文献数据更新至2024年12月31日

  • Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation
    Journal: Biochemical Pharmacology 引用产品:anti-GAPDH antibody(MB001)
    ApplicationWB
    IF4.825
    SpeciesRat,Human
  • Ginsenoside Rd ameliorates colitis by inducing p62-driven mitophagy-mediated NLRP3 inflammasome inactivation in mice
    Journal: Biochemical Pharmacology 引用产品:Horseradish peroxidase (HRP) conjugated second antibodies(BS13278/BS12478/BS30503)
    ApplicationWB
    IF4.825
    SpeciesHuman,Mouse
  • Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway
    Journal: Biochemical Pharmacology 引用产品:peroxidase-conjugated secondary antibodies()
    ApplicationWB
    IF4.825
    SpeciesMouse,Human
  • Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway
    Journal: Biochemical Pharmacology 引用产品:protein A+G agarose(BD0045)
    Application
    IF4.825
    Species
  • Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway
    Journal: Biochemical Pharmacology 引用产品:Annexin V-FITC/PI(BD0073-1)
    Application
    IF4.825
    Species
  • Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway
    Journal: Biochemical Pharmacology 引用产品:cell counting kit-8 (CCK-8)(BD0079-1)
    Application
    IF4.825
    Species
  • A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan
    Journal: Journal of Immunology Research 引用产品:Anti-EGFR Antibody(pY1068/1173)
    ApplicationWB
    IF4.818
    SpeciesHuman
  • A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan
    Journal: Journal of Immunology Research 引用产品:Anti-AKT Antibody()
    ApplicationWB
    IF4.818
    SpeciesHuman
  • A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan
    Journal: Journal of Immunology Research 引用产品:Anti-pAKT Antibody()
    ApplicationWB
    IF4.818
    SpeciesHuman
  • A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan
    Journal: Journal of Immunology Research 引用产品:Anti-ERK Antibody()
    ApplicationWB
    IF4.818
    SpeciesHuman

关注我们

400-660-9091

电话:025-68037686

地址:江苏生命科技创新园F6幢1层

订购:nanjing03@biogot.com

服务:biorase01@biogot.com

合作:lvyun@biogot.com

支持:may@biogot.com